SRC KINASE INHIBITOR COMPOUNDS

摘要

Pyrimidine compounds (Formula I), or their pharmaceutically acceptable salts , hydrates, solvates, crystal forms and individual diastereomers, and pharmaceutical compositions including the same, which are inhibitors of tyrosine kinase enzymes, and as such are useful in the prophylaxis and treatment of protein tyrosine kinase-associated disorders, such as immune diseases, hyperproliferative disorders and other diseases in which inappropriate protein kinase action is believed to play a role, such as cancer, angiogenesis, atheroscelerosis, graft rejection, rheumatoid arthriti s and psoriasis.